Form 4: Colgate-Palmolive Director John T. Cahill Reports Stock and Option Grants

Sentiment:

SEC Form 4


Director John T. Cahill reports acquisition of common stock and stock options from Colgate-Palmolive under the company's incentive compensation plan.

Summary

  • On May 13, 2024, John T. Cahill, a director of Colgate-Palmolive, reported transactions involving the company's securities.
  • Cahill acquired 1,905 shares of common stock at $0.00 per share as an annual director stock grant under the issuer's incentive compensation plan.
  • He also acquired a stock option for 2,201 shares with an exercise price of $94.46, also as part of the annual director stock option grant.
  • The stock option becomes exercisable in equal annual installments over three years, starting on May 13, 2025.
  • Following these transactions, Cahill directly owns 26,890 shares of common stock and indirectly owns 32,433 shares through a trust.
  • He also directly owns options for 2,201 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard compensation practices and aligns director interests with shareholders. There are no indications of negative events or concerns.

Positives

  • The stock and option grants are part of Colgate-Palmolive's incentive compensation plan, aligning director interests with company performance.
  • The vesting schedule of the stock options encourages long-term commitment from the director.

Industry Context

This filing is a routine disclosure of stock and option grants to a company director, which is a common practice in publicly traded companies to incentivize and align the interests of directors with those of shareholders.

Comparison to Industry Standards

  • Stock option grants to directors are a standard practice among publicly traded companies, including Colgate-Palmolive's peers such as Procter & Gamble (PG) and Unilever (UL).
  • The size and vesting schedule of the grants are generally aligned with industry norms for director compensation.
  • Companies like Johnson & Johnson (JNJ) also utilize similar incentive plans to reward and retain their board members.

Stakeholder Impact

  • The stock and option grants align the director's interests with those of shareholders, potentially leading to better corporate governance and decision-making.
  • Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
05/13/2024Date of the stock and option grants.
05/13/2025First anniversary of the grant date, when the options begin to vest.
05/13/2032Expiration date of the stock options.
05/15/2024Date of signature by Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.